![]() |
|
|
Vol. 289, Issue 1, 346-353, April 1999
Faculty of Pharmacy, Silpakorn University, Nakorn-Pathom, Thailand
(N.P.);
College of Pharmacy, University of Michigan, Ann Arbor,
Michigan (C.L., D.F.); University Renal Research and Education
Associates, Ann Arbor, Michigan
In previous studies, sulfoxide metabolite was observed in animal and
human intestinal perfusions of cimetidine and other
H2-antagonists. A sequence of follow-up studies is ongoing
to assess the intestinal contributions of drug metabolism and drug and
metabolite transport to variable drug absorption. An evaluation of
these contributions to absorption variability is carried out in
isolated fractions of the absorptive cells to uncouple the processes
involved. In this report, data is presented on the drug entry step from
a study on [3H]cimetidine uptake into isolated
brush-border membrane vesicles from rat small intestine. A saturable
component for cimetidine uptake was characterized with a
Vmax and Km
(mean ± S.E.M.) of 6.1 ± 1.5 nmol/30s/mg protein and
8.4 ± 2.0 mM, respectively. Initial binding, and possibly
intravesicular uptake, was inhibited by other cationic compounds
including ranitidine, procainamide, imipramine, erythromycin, and
cysteamine but not by TEA or by the organic anion, probenecid. Initial
uptake was not inhibited by amino acids methionine, cysteine, or
histidine, by the metabolite cimetidine sulfoxide, or by inhibitors of
cimetidine sulfoxidation, methimazole, and
diisothiocyanostilbene-2,2'-disulfonic acid. Equilibrium uptake
was inhibited by ranitidine, procainamide, and cysteamine but not by
erythromycin or imipramine. Initial cimetidine uptake was stimulated by
an outwardly directed H+ gradient, and efflux was enhanced
by an inwardly directed H+ gradient. Collapse of the
H+ gradient as well as voltage-clamping potential
difference to zero significantly reduced initial cimetidine uptake. The
data is supportive of both a cimetidine/H+ exchange
mechanism and a driving-force contribution from an inside negative
proton or cation diffusion potential.
This article has been cited by other articles:
![]() |
K. Lee, C. Ng, K. L. R. Brouwer, and D. R. Thakker Secretory Transport of Ranitidine and Famotidine across Caco-2 Cell Monolayers J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Katsura, H. Mizuuchi, Y. Hashimoto, and K.-I. Inui Transport of procainamide via H+/tertiary amine antiport system in rabbit intestinal brush-border membrane Am J Physiol Gastrointest Liver Physiol, October 1, 2000; 279(4): G799 - G805. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Piyapolrungroj, Y. S. Zhou, C. Li, G. Liu, E. Zimmermann, and D. Fleisher Cimetidine Absorption and Elimination in Rat Small Intestine Drug Metab. Dispos., January 1, 2000; 28(1): 65 - 72. [Abstract] [Full Text] |
||||